Search

Your search keyword '"Aldersley, Mark"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Aldersley, Mark" Remove constraint Author: "Aldersley, Mark" Language english Remove constraint Language: english
29 results on '"Aldersley, Mark"'

Search Results

3. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

4. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

5. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

6. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

7. FRI-374-YI The UK experience of liver transplantation for HBV: excellent clinical outcomes despite a significant burden of HBV/Delta disease and wide variation in hepatitis B immunoglobulin prophylaxis practices-time for a consistent approach?

8. The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-Term Prediction of End-Stage Liver Disease in Primary Biliary Cholangitis

9. Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK.

12. Reply to: “Reply to: ‘Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries’”

13. OS005 - Excess mortality risk among hepatitis C patients after being “cured” in the interferon-free era: results from three population-based cohorts

14. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

19. Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.

20. Liver transplant listing for hepatitis C‐associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct‐acting antiviral therapy.

28. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

29. Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.

Catalog

Books, media, physical & digital resources